Phospholamban Antikörper (N-Term)
(1 reference)-
- Target Alle Phospholamban (PLN) Antikörper anzeigen
- Phospholamban (PLN)
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Phospholamban Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of PLN.
- Spezifität
- Identical to the related rat and mouse sequence.
- Kreuzreaktivität
- Human, Maus, Ratte
- Immunogen
- A synthetic peptide corresponding to amino acids at N-terminus of human PLN.
- Isotyp
- IgG
- Top Product
- Discover our top product PLN Primärantikörper
-
anti-Phospholamban (PLN) (AA 1-52) antibody
PLN Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) (AA 1-30) antibodyPLN Reaktivität: Human ELISA, WB, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) (pSer16) antibodyPLN Reaktivität: Human ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) (AA 1-22), (N-Term) antibodyPLN Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB44799 unconjugated
anti-Phospholamban (PLN) (pThr17) antibodyPLN Reaktivität: Human, Ratte WB, DB Wirt: Kaninchen Polyclonal RB24137 unconjugated
anti-Phospholamban (PLN) (N-Term) antibodyVerified PLN Reaktivität: Human, Ratte ELISA, WB, IHC Wirt: Ziege Polyclonal unconjugated
anti-Phospholamban (PLN) (Thr17) antibodyPLN Reaktivität: Human WB, IHC (p), FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) (AA 1-52) antibodyPLN Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) (AA 1-35) antibodyPLN Reaktivität: Human ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholamban (PLN) antibodyPLN Reaktivität: Human, Ratte, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot (1 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized from 0.9 mg NaCl, 0.2 mg Na2HPO4 (5 mg BSA, 0.05 mg sodium azide, 0.05 mg Thimerosal)
- Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate) and Sodium azide: POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C on dry atmosphere.
After reconstitution with 200 uL of deionized water and concentration will be 500 ug/mL, store at -20°C or lower.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Phospholamban: a key determinant of cardiac function and dysfunction." in: Archives des maladies du coeur et des vaisseaux, Vol. 98, Issue 12, pp. 1239-43, (2006) (PubMed).
-
: "Phospholamban: a key determinant of cardiac function and dysfunction." in: Archives des maladies du coeur et des vaisseaux, Vol. 98, Issue 12, pp. 1239-43, (2006) (PubMed).
-
- Target
- Phospholamban (PLN)
- Andere Bezeichnung
- Phospholamban (PLN Produkte)
- Synonyme
- LOC100226261 antikoerper, plb antikoerper, cmd1p antikoerper, CMD1P antikoerper, CMH18 antikoerper, PLB antikoerper, Plb antikoerper, Plm antikoerper, phospholamban antikoerper, PLN antikoerper, pln antikoerper, Pln antikoerper
- Gen-ID
- 5350
- Pathways
- Negative Regulation of Transporter Activity
-
